
Approvals· May 28, 2026 · 7 min read
Baxfendy coverage guide: baxdrostat access for uncontrolled hypertension
By Ran Chen#Hypertension#Cardiovascular#FDA Approval
First-in-class drug approvals, novel mechanisms of action, new drug class launches, and formulary and access implications for therapies with no prior-class precedent.
